• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

OMER:US

14.6100 USD 0.1400 0.95%

As of 20:10:00 ET on 07/10/2014.

Snapshot for Omeros Corp (OMER)

Open: 14.3000 Day's Range: 14.1301 - 14.9100 Volume: 338,938
Previous Close: 14.7500 52wk Range: 4.7500 - 18.8000 1-Yr Rtn: +151.90%

Stock Chart for OMER

No chart data available.
  • OMER:US 14.6100
  • 1D
  • 1M
  • 1Y
14.7500
Interactive OMER Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OMER

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8092
Est. EPS (USD) (12/2014) -1.8200
Est. PEG Ratio -
Market Cap (M USD) 495.46
Shares Outstanding (M) 33.91
30 Day Average Volume 558,238
Price/Book (mrq) 95.0311
Price/Sale (ttm) 718.0035
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OMER

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OMER

Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.

Gregory A DemopulosChairman/Pres/CEO/Co-FounderMichael A JacobsenVP:Finance/Chief Acctg Officer
George A GaitanarisVP:Science/Chief Scientific OfcrJ Steven WhitakerVP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for OMER

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil